Diagnos Inc.
DGNOF
$0.142
$0.00674.95%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 74.80K | 93.20K | 112.90K | 120.70K | 126.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.80K | 93.20K | 112.90K | 120.70K | 126.10K |
| Cost of Revenue | 750.70K | 728.50K | 698.80K | 678.30K | 747.60K |
| Gross Profit | -675.90K | -635.40K | -586.00K | -557.70K | -621.60K |
| SG&A Expenses | 2.06M | 1.69M | 1.48M | 1.32M | 1.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.81M | 2.42M | 2.18M | 2.00M | 2.06M |
| Operating Income | -2.74M | -2.33M | -2.06M | -1.88M | -1.93M |
| Income Before Tax | -3.07M | -2.74M | -2.47M | -2.28M | -2.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.07 | -2.74 | -2.47 | -2.28 | -2.31 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.07M | -2.74M | -2.47M | -2.28M | -2.31M |
| EBIT | -2.74M | -2.33M | -2.06M | -1.88M | -1.93M |
| EBITDA | -2.66M | -2.25M | -1.99M | -1.80M | -1.86M |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 353.04M | 329.01M | 308.25M | 298.16M | 291.36M |
| Average Diluted Shares Outstanding | 353.04M | 329.01M | 308.25M | 298.16M | 291.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |